Bastian Thomas W, von Hohenberg William C, Mickelson Daniel J, Lanier Lorene M, Georgieff Michael K
Department of Pediatrics and Center for Neurobehavioral Development, School of Medicine, Minneapolis, Minn., USA.
Dev Neurosci. 2016;38(4):264-276. doi: 10.1159/000448514. Epub 2016 Sep 27.
Iron deficiency (ID), with and without anemia, affects an estimated 2 billion people worldwide. ID is particularly deleterious during early-life brain development, leading to long-term neurological impairments including deficits in hippocampus-mediated learning and memory. Neonatal rats with fetal/neonatal ID anemia (IDA) have shorter hippocampal CA1 apical dendrites with disorganized branching. ID-induced dendritic structural abnormalities persist into adulthood despite normalization of the iron status. However, the specific developmental effects of neuronal iron loss on hippocampal neuron dendrite growth and branching are unknown. Embryonic hippocampal neuron cultures were chronically treated with deferoxamine (DFO, an iron chelator) beginning at 3 days in vitro (DIV). Levels of mRNA for Tfr1 and Slc11a2, iron-responsive genes involved in iron uptake, were significantly elevated in DFO-treated cultures at 11DIV and 18DIV, indicating a degree of neuronal ID similar to that seen in rodent ID models. DFO treatment decreased mRNA levels for genes indexing dendritic and synaptic development (i.e. BdnfVI,Camk2a,Vamp1,Psd95,Cfl1, Pfn1,Pfn2, and Gda) and mitochondrial function (i.e. Ucp2,Pink1, and Cox6a1). At 18DIV, DFO reduced key aspects of energy metabolism including basal respiration, maximal respiration, spare respiratory capacity, ATP production, and glycolytic rate, capacity, and reserve. Sholl analysis revealed a significant decrease in distal dendritic complexity in DFO-treated neurons at both 11DIV and 18DIV. At 11DIV, the length of primary dendrites and the number and length of branches in DFO-treated neurons were reduced. By 18DIV, partial recovery of the dendritic branch number in DFO-treated neurons was counteracted by a significant reduction in the number and length of primary dendrites and the length of branches. Our findings suggest that early neuronal iron loss, at least partially driven through altered mitochondrial function and neuronal energy metabolism, is responsible for the effects of fetal/neonatal ID and IDA on hippocampal neuron dendritic and synaptic maturation. Impairments in these neurodevelopmental processes likely underlie the negative impact of early life ID and IDA on hippocampus-mediated learning and memory.
缺铁(ID),无论是否伴有贫血,据估计全球约有20亿人受其影响。缺铁在生命早期的大脑发育过程中尤其有害,会导致长期的神经功能障碍,包括海马体介导的学习和记忆缺陷。患有胎儿/新生儿缺铁性贫血(IDA)的新生大鼠海马CA1区顶端树突较短,分支紊乱。尽管铁状态恢复正常,但缺铁引起的树突结构异常会持续到成年期。然而,神经元铁流失对海马神经元树突生长和分支的具体发育影响尚不清楚。从体外培养第3天(DIV)开始,用去铁胺(DFO,一种铁螯合剂)对胚胎海马神经元培养物进行长期处理。在11DIV和18DIV时,参与铁摄取的铁反应基因Tfr1和Slc11a2的mRNA水平在DFO处理的培养物中显著升高,表明神经元缺铁程度与啮齿动物缺铁模型相似。DFO处理降低了与树突和突触发育相关基因(即BdnfVI、Camk2a、Vamp1、Psd95、Cfl1、Pfn1、Pfn2和Gda)以及线粒体功能相关基因(即Ucp2、Pink1和Cox6a1)的mRNA水平。在18DIV时,DFO降低了能量代谢的关键指标,包括基础呼吸、最大呼吸、备用呼吸能力、ATP产生以及糖酵解速率、能力和储备。Sholl分析显示,在11DIV和18DIV时,DFO处理的神经元远端树突复杂性显著降低。在11DIV时,DFO处理的神经元初级树突长度以及分支数量和长度均减少。到18DIV时,DFO处理的神经元树突分支数量的部分恢复被初级树突数量和长度以及分支长度的显著减少所抵消。我们的研究结果表明,早期神经元铁流失,至少部分是由线粒体功能和神经元能量代谢改变驱动的,是胎儿/新生儿缺铁和缺铁性贫血对海马神经元树突和突触成熟产生影响的原因。这些神经发育过程的损伤可能是早期缺铁和缺铁性贫血对海马体介导的学习和记忆产生负面影响的基础。